Anna Skiada
Impact in
- Infectious Diseases top 0.1%
- Antifungal resistance and susceptibility
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 32
-
- Antibiotic Resistance in Bacteria 17
- Co-authors
- George L. Petrikkos (17 shared papers)Emmanuel Roilides (5 shared papers)Olivier Lortholary (3 shared papers)Maria Drogari‐Apiranthitou (6 shared papers)Thomas J. Walsh (2 shared papers)Dimitrios P. Kontoyiannis (2 shared papers)Ioannis Pavleas (5 shared papers)Cornelia Lass‐Flörl (3 shared papers)
In The Last Decade
Anna Skiada
61 papers receiving 9.5k citations
Anna Skiada's Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 7.2k
- Molecular Medicine 1.3k
- Microbiology 99
- Applied Microbiology and Biotechnology 155
- Small Animals 251
Countries citing papers authored by Anna Skiada
This map shows the geographic impact of Anna Skiada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Skiada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Skiada more than expected).
Fields of papers citing papers by Anna Skiada
This network shows the impact of papers produced by Anna Skiada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Skiada. The network helps show where Anna Skiada may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Skiada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Hit paper breakdown → | 2019 | 1223 |
| 2 | Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Hit paper breakdown → | 2018 | 1188 |
| 3 | Epidemiology and Clinical Manifestations of Mucormycosis Hit paper breakdown → | 2012 | 1071 |
| 4 | ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 Hit paper breakdown → | 2014 | 708 |
| 5 | Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 Hit paper breakdown → | 2011 | 603 |
| 6 | Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial Hit paper breakdown → | 2018 | 513 |
| 7 | ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients Hit paper breakdown → | 2016 | 503 |
| 8 | ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others Hit paper breakdown → | 2014 | 425 |
| 9 | 2020 | 424 | |
| 10 | 2017 | 419 | |
| 11 | Challenges in the diagnosis and treatment of mucormycosis Hit paper breakdown → | 2017 | 386 |
| 12 | 2012 | 290 | |
| 13 | 2014 | 284 | |
| 14 | 2016 | 125 | |
| 15 | 2003 | 107 | |
| 16 | 2007 | 106 | |
| 17 | 2018 | 102 | |
| 18 | 2009 | 94 | |
| 19 | 2015 | 92 | |
| 20 | 2012 | 84 |
About Anna Skiada
Anna Skiada is a scholar working on Infectious Diseases, Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology and Epidemiology, having authored 61 papers that have together received 9.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (32 papers), Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Fungal Infections and Studies (3 papers), Infective Endocarditis Diagnosis and Management (2 papers), Antibiotic Use and Resistance (2 papers), Iron Metabolism and Disorders (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Infectious Diseases (7.2k citations), Molecular Medicine (1.3k citations), Microbiology (99 citations), Applied Microbiology and Biotechnology (155 citations) and Small Animals (251 citations). Anna Skiada has collaborated with scholars based in Greece, Italy and Israel. Frequent co-authors include George L. Petrikkos, Emmanuel Roilides, Olivier Lortholary, Maria Drogari‐Apiranthitou, Thomas J. Walsh, Dimitrios P. Kontoyiannis, Ioannis Pavleas, Cornelia Lass‐Flörl, Andreas H. Groll and Livio Pagano. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Fungi, International Journal of Antimicrobial Agents, Clinical Infectious Diseases and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.